Sign in

CIK 0001553643

  • Non-accelerated filer
  • Smaller reporting company

RELMADA THERAPEUTICS, INC.

Sign in to watch
Ticker
RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
455401931
Phone
+1 646-876-3459
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Former names
CAMP NINE, INC.
  1. 4 Open-market sale Director sold 5,000 shares at an average $35.71 ($178,551)
  2. 4 Open-market sale CFO sold 10,000 shares at an average $35.45 ($354,507)
  3. 4 Open-market sale Director sold 3,000 shares at $33.87 ($101,618)
  4. 4 Open-market sale CEO sold 10,000 shares at an average $34.24 ($342,392)
  5. 4 Open-market sale Director sold 5,000 shares at an average $34.19 ($170,933)
  6. 4 Open-market sale CFO sold 3,000 shares at an average $34.18 ($102,529)
  7. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  8. 4 Open-market sale CEO sold 1,446 shares at $35.43 ($51,238)
  9. 4 Open-market sale CFO sold 1,428 shares at $35.39 ($50,542)
  10. 4 Open-market sale CEO sold 11,206 shares at an average $35.17 ($394,085)
  11. 4 Open-market sale Director sold 3,569 shares at an average $35.18 ($125,565)
  12. 4 Open-market sale CFO sold 11,372 shares at an average $35.17 ($399,910)
  13. 4 Exercise or conversion CEO acquired 13,281 shares (option exercise)
  14. 4 Open-market sale CEO sold 3,278 shares at an average $35.07 ($114,970)
  15. 4 Open-market sale CFO sold 3,200 shares at an average $35.04 ($112,134)
  16. 4 Open-market sale Director sold 2,346 shares at an average $35.04 ($82,203)
  17. 4 Open-market sale Director sold 3,000 shares at an average $33.63 ($100,898)
  18. 4 Open-market sale CFO sold 3,000 shares at an average $31.93 ($95,778)
  19. 4 Open-market sale CEO sold 10,000 shares at an average $32.39 ($323,914)
  20. 4 Open-market sale Director sold 5,000 shares at an average $32.46 ($162,323)

Page 6 of 10 · 200 filings